Controlling drug delivery across the placenta

European Journal of Pharmaceutical Sciences

Volumn 8, Issue 3, 1999, Pages 161-165

  Audus, Kenneth L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Drugs; Metabolism; P glycoprotein; Placenta; Transport

Indexed keywords

DRUG; GLYCOPROTEIN P;

ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; METABOLISM; NONHUMAN; PLACENTA; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

DRUG THERAPY; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PLACENTA; PREGNANCY;

EID: 0033165903     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(99)00031-7     Document Type: Article

References (37)

1. Ala-Kokko T.I., Vahakangas K., Pelkonen O. Placental function and principles of drug transfer. Acta Anaesthesiol. Scand. 37:1993;47-49.
2. Allen J.R., Barsotti D.A. The effects of transplacental and mammary movements of PCBs on infant rhesus monkeys. Toxicology. 6:1976;331-340.
3. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:1998;5337-5339.
4. Bassily M., Ghabrial H., Smallwood R.A., Morgan D.J. Determinants of placental drug transfer: Studies in the isolated perfused human placenta. J. Pharm. Sci. 84:1995;1054-1060.
5. Bloxam D.L., Bax B.E., Bax C.M.R. Culture of syncytiotrophoblasts for the study of human placental transfer. Part II: Production, culture and use of syncytiotrophoblast. Placenta. 18:1997;99-108.
6. Chandorkar G.A., Ampasavate C., Stobaugh J.F., Audus K.L. Peptide transport and metabolism across the placenta. Adv. Drug Del. Rev. 38:1999;59-68.
7. Dancis J., 1987. Placental physiology. In: Kretchmer, N., Quilligan E.J., Johnson J.D. (Eds.), Prenatal and Perinatal Biology and Medicine, Physiology and Growth, Vol. 1, Harwood Academic Publishers, Chur, Switzerland, pp. 1-33.
8. Dancis J., Liebes L. Drug delivery during pregnancy: evaluation in vitro of new drugs. Reprod. Fertil. Dev. 7:1995;1485-1489.
9. Enders A.C., Blankenship T.N. Comparative placental structure. Adv. Drug Del. Rev. 38:1999;3-16.
10. Ganapathy V., Prasad P.D., Ganapathy M.E., Leibach F.H. Drugs of abuse and placental transport. Adv. Drug Del. Rev. 38:1999;99-110.
11. Johnson A.R., Skidgel R.A., Gaffort J.T., Erdös E.G. Enzymes in placental microvilli: Angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase ('enkephalinase'). Peptides. 5:1994;789-796.
12. Kenagy J., Liu F., Soares M.J., Audus K.L. Gestational and smoking effects on peptidase activity in the placenta. Peptides. 19:1998;1659-1666.
13. Khera K.S., Ruddick J.A. Polychlorodibenzo-p-dioxins: perinatal effects and the dominant lethal test in Wistar rats. Blair E.H., Chlorodioxins - Origin and Fate, Advances in Chemistry Series 120. 1972;70-84 American Chemical Society, Washington, DC.
14. Knipp G.T., Audus K.L., Soares M.J. Nutrient transport across the placenta. Adv. Drug Del. Rev. 38:1999;41-58.
15. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12:1998;457-463.
16. Liu F., Soares M.J., Audus K.L. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am. J. Physiol. 273:1997;C1596-C1604.
17. Macfarland A., Abramovich D.R., Ewen S.W.B., Pearson C.K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term placenta. Histochem. J. 26:1994;417-423.
18. Malek A., Blann E., Mattison D.R. Human placental transport of oxytocin. J. Maternal-Fetal Med. 5:1996;245-255.
19. Moe A.J. Placental amino acid transport. Am. J. Physiol. 268:1995;C1321-1331.
20. Mylona P., Glazier J.D., Greenwood S.L., Slides M.K., Sibley C.P. Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol. Hum. Reprod. 2:1996;693-698.
21. Nakamura Y., Ikeda S., Furukawa T., Sumizawa T., Tani A., Akiyama S., Nagata Y. Function of P-glycoprotein expressed in placenta and mole. Biochem. Biophys. Res. Commun. 235:1997;849-853.
22. Parry S., Hideki K., Strauss J.F. III. Gene and viral delivery to the trophoblast. Adv. Drug Del. Rev. 38:1999;69-80.
23. Pasanen M. The expression and regulation of drug metabolism in human placenta. Adv. Drug Del. Rev. 38:1999;81-98.
24. Ramamoorthy J.D., Ramamoorthy S., Leibach F.H. Leib, Ganapathy V. Human placental monoamine transporters as targets for amphetamines. Am. J. Obstet. Gynecol. 173:1995;1782-1787.
25. Rapaka R.S., Porreca F. Development of delta opioid peptides as nonaddicting analgesics. Pharm. Res. 8:1991;1-8.
26. Ringler G.E., Strauss J.F. III. In vitro systems for the study of human placental endocrine function. Endocr. Rev. 11:1990;105-123.
27. Robinson N.R., Atkinson D.E., Jones C.J.P., Sibley C.P. Permeability of the near-term rat placenta to hydrophilic solutes. Placenta. 9:1988;361-371.
28. Sastry B.V.R. Techniques to study human placental transport. Adv. Drug Del. Rev. 38:1999;17-40.
29. Shum S., Jensen N.M., Nebert D.W. The murine Ah locus: in utero toxicity and teratogenesis is associated with genetic differences in benzo(a)pyrene metabolism. Teratology. 20:1979;365-376.
30. Sibley C.P. Review article: Mechanisms of ion transfer by the rat placenta: a model for the human placenta? Placenta. 15:1994;675-691.
31. Stulc J., Stulcova B. Asymmetrical transfer of inert solutes across the rat placenta. Am. J. Physiol. 265:1993;R670-R675.
32. Tuntland T., Odinecs A., Pereira C.M., Nosbisch C., Unadkat J.D. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am. J. Obstet. Gynecol. 180:1999;198-206.
33. Utoguchi N., Chandorkar G.A., Audus K.L. Investigation of functional expression of P-glycoprotein (Pgp) and multidrug resistant protein (MRP) in BeWo cell (trophoblast) monolayers, a model of the placental barrier. Pharm. Sci. 1:1998;S654.
34. Willis D.M., O'Grady J.P., Faber J.J., Thornburg K.L. Diffusion permeability of cyanocobalamin in human placenta. Am. J. Physiol. 250:1986;R459-R464.
35. Wong T.K., Everson R.B., Hsu S.-T. Potent induction of human placental mfo-oxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet. i:1985;721-724.
36. Yaffe S.J. Introduction. Briggs G., Freeman R.K., Yaffe S.J., Drugs in Pregnancy and Lactation. 1998;xiii-xix Williams & Wilkins, Baltimore, MD.
37. Yui J., Garcia-Lloret M., Brown A.J., Berdan R.C., Morrish D.W., Wegmann T.G., Guilbert L.J. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta. 15:1994;231-246.